Amarin Corp Plc (AMRN)

[couldbebetter]

Indeed, Unless AMRN is hiring reps with long standing relationships with
the same doctors they will be detailing Vascepa to (not likely as why
would they be leaving a position where they have already had success)
Vascepa would have a better shot with the reps that already have such
long standing relationships, but those reps are likely gainfully
employed by BP. Doing a distribution deal usually does not work
out very well. If a BP owned AMRN, the BP could take advantage
of their reps (hopefully) long standing relationships by offering
them special incentives to ramp up Vascepa scrips. This is why
AMRN should be in the hands of a BP which has a strong Cardiovascular
and Endocrinologist sales team. In Europe there is no direct to
consumer advertising so AMRN will either have to select a distribution
partner or entertain takeout offers from BP with interest in Europe.
(Wonder if AMRN's direct to consumer adds will bleed through into Canada
and eventually impact demand there once Vascepa is actually available.
Might want to ramp up TV advertising in Buffalo, NY if that is the
case...assuming they can even get the same stations.)